-- 根据深圳海普林制药（港交所代码：9989，深交所代码：002399）周三在香港联交所发布的公告，该公司第一季度归属于股东的净利润为1.876亿元人民币，较上年同期的1.566亿元人民币增长20%。 周四上午交易时段，该公司在香港上市的股票上涨超过1%。 每股收益为0.1278元人民币，高于上年同期的0.1067元人民币。 营业收入同比下降4.6%，从上年同期的13.9亿元人民币降至13.3亿元人民币。
Related Articles
Asia
Fudan-Zhangjiang Bio-Pharma's Profit Jumps 189% in Q1
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349, SHA:688505) posted net profit attributable to shareholders of 7.7 million yuan for the first quarter, up 189% from 2.7 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Hong Kong-listed shares of the biotech firm were up nearly 2% in recent trade.Earnings per share came in at 0.01 yuan, compared with a near-zero figure a year earlier.Revenue fell 17% to 149.1 million yuan from 179.9 million yuan in the prior-year period.
$HKG:1349$SHA:688505
Asia
Coliwoo Forecasts Higher Net Profit in Fiscal H1
Coliwoo (SGX:W8W) is expecting to book a higher net profit before tax for the fiscal first half ended March 31, according to a Wednesday filing with the Singapore Exchange.The co-living provider has attributed this to net fair value gains on its investment properties during the period.
$SGX:W8W
Asia
Hot Chili Plans to Accelerate Drilling Across Chile Copper-Gold Porphyry Discovery
Hot Chili (ASX:HCH) plans to accelerate drilling across the La Verde copper-gold porphyry discovery in Chile to establish a maiden mineral resource and further define the potential size, scale, and grade of a higher-grade starter pit for the Costa Fuego project, also in Chile, according to a Thursday Australian bourse filing.The company said it plans to complete and submit an environmental impact assessment for Costa Fuego and start a feasibility study for the project.Hot Chili intends to integrate La Verde into an expanded mine plan.
$ASX:HCH